🟢 Encompass Health is trading 6% up today after Q3 earnings beat and higher guidance

Encompass Health is trading at $129.00, up 5.66%, after its Q3 earnings beat and higher full-year outlook.

• The October 28 report showed Q3 adjusted EPS of $1.52, above the $1.36 analyst estimate.
• Revenue was $1.61 billion, above $1.60 billion.
• Management raised full-year adjusted EPS guidance to $6.23–$6.37 and revenue guidance to $6.45–$6.50 billion.